Accéder au contenu
Merck

Pyrrolo[3,2-h]quinazolines as photochemotherapeutic agents.

ChemMedChem (2011-05-17)
Paola Barraja, Libero Caracausi, Patrizia Diana, Alessandra Montalbano, Anna Carbone, Alessia Salvador, Paola Brun, Ignazio Castagliuolo, Silvia Tisi, Francesco Dall'Acqua, Daniela Vedaldi, Girolamo Cirrincione
RÉSUMÉ

Heteroanalogues of angelicin, pyrrolo[3,2-h]quinazolines, were synthesized with the aim of obtaining new potent photochemotherapeutic agents. Many derivatives caused a significant decrease in cell proliferation in several human tumor cell lines after irradiation with UVA light (GI(50) =15.2-0.2 μM). Their phototoxicity effected apoptosis in Jurkat cells with the involvement of mitochondria (as determined by the loss of mitochondrial membrane potential and production of reactive oxygen species) and lysosomes. The phototoxicity of these compounds could be explained by lipid peroxidation.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Angelicin